T1-P15 A new Plasmodium vivax reference genome for South American isolates Katlijn De Meulenaere 1,2 , Bart Cuypers 2 , Dionicia Gamboa 3,4 , Kris Laukens 2 , Anna Rosanas-Urgell 1 1 Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium
Objective: To synthesize how medicinefood homology (MFH) compounds from Traditional Chinese Medicine (TCM)polysaccharides, saponins/triterpenoids, polyphenols, carotenoids, and aromatic phenylpropanoidsmodulate oxidative stress and PD-related neurodegeneration, and to outline formulation routes toward dietary-supplement development
reported that the anti-HGF mAb ficlatuzumab significantly inhibited the c-MET activation and rescued the capacity of cetuximab to inhibit the phosphorylation of EGFR in cetuximab-resistant CRC cell lines LM1215, SW48, and DiFi ( Rilotumumab , a fully human anti-HGF mAb that neutralizes HGF-dependent c-MET signaling, has been investigated in phase Ib/II trial (NCT00788957) in combination with panitumumab in previously treated patients with KRAS-WT mCRC
1 Our formula provides powerful intracellular antioxidant support and encourages healthy liver function